InflaRx (IFRX) Change in Inventory (2023 - 2025)
InflaRx (IFRX) posted Change in Inventory of $5.9 million for Q4 2025, up 15434.36% sequentially from -$38497.0 in Q3 2025, and up 95.81% YoY from $3.0 million in Q4 2024.
InflaRx (IFRX) Change in Inventory (2023 - 2025) Analysis & Trends
InflaRx has reported Change in Inventory for 3 years, with the latest figure at $5.9 million in Q4 2025.
- Quarterly Change in Inventory rose 95.81% year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.0 million (up 66.31% YoY) and the FY2025 annual result came in at $7.8 million, up 61.07% from the prior year.
- Change in Inventory grew to $5.9 million in Q4 2025 per IFRX's latest filing, from -$38497.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $5.9 million in Q4 2025 and troughed at -$10.5 million in Q4 2023.
- A 3-year average of $113921.5 and a median of $174569.7 in 2024 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2024 and 2025: Change in Inventory surged 128.8% in 2024, then slumped 99.3% in 2025.
- Over 3 years, Change in Inventory stood at -$10.5 million in 2023, then soared by 128.8% to $3.0 million in 2024, then soared by 95.81% to $5.9 million in 2025.
- According to Business Quant data, Change in Inventory over the past three periods registered $5.9 million, -$38497.0, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.90 Mn |
| Dec 31, 2025 | 5.90 Mn |
| Sep 30, 2025 | -38,496.98 |
| Sep 30, 2025 | -38,496.98 |
| Jun 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 2,414.07 |
| Mar 31, 2025 | 2,414.07 |
| Dec 31, 2024 | 3.01 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | -81,972.20 |
| Sep 30, 2024 | -81,972.20 |
| Jun 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 346,725.39 |
| Mar 31, 2024 | 346,725.39 |
| Dec 31, 2023 | -10.47 Mn |
| Dec 31, 2023 | -10.47 Mn |
| Sep 30, 2023 | -1.15 Mn |
| Sep 30, 2023 | -1.15 Mn |